|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.1 TWD | 0.00% |
|
-0.33% | -29.27% |
Vectorite Biomedical Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 55.85 million compared to TWD 42.91 million a year ago. Net loss was TWD 6.6 million compared to TWD 26.41 million a year ago.
Basic loss per share from continuing operations was TWD 0.15 compared to TWD 0.6 a year ago. Diluted loss per share from continuing operations was TWD 0.15 compared to TWD 0.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.27% | 20.53M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
VECTORITE BIOMEDICAL INC. 